baber/WOPTO huggingface dataset:
Patent AU-2020288448-A1 (AU)
Title: Oropharyngeal device for maintaining an airway
Inventor: SCOTT PAUL
IPC: A61M16/06
Filed: 2020-06-04
Abstract: A sealing apparatus for use in combination with an oropharyngeal device for maintaining a patient airway, the oropharyngeal device having a hollow airway tube with proximal end and a distal end, the proximal end being adapted to be fluidly coupled with a supply of gas for passage of air or medical gas wherein the device is adapted for insertion through the mouth of a patient and with one end into the pharynx of a patient above and spaced from the epiglottis of the patient, the sealing apparatus comprising: a flexible sheet adapted to be placed over a user's face; and the flexible sheet comprising an opening to allow the distal end of the tube to be passed therethrough, the opening being dimensioned to prevent the proximal end of the tube from being passed through the opening.
Patent AU-2020289131-A1 (AU)
Title: A roof rack coupler
Inventor: HOLZ BILL
IPC: B60R9/048
Filed: 2020-06-04
Abstract: The present invention relates to a roof rack coupler for coupling an accessory to a roof rack. The coupler includes a roof rack member for fastening to the generic roof rack bracket. The coupler further includes an accessory member, typically releasably fastenable to the accessory, for engaging with the roof rack member. Securing means is provided for securing the accessory member to the roof rack member. Preferably, the accessory member may be dropped within and lifted out of the roof rack member to facilitate rapid assembly and disassembly.
Patent AU-2020289352-A1 (AU)
Title: Techniques for file versioning to protect against file corruption
Inventor: BLAIR JOHN DAVID
IPC: G06F21/64
Filed: 2020-06-04
Abstract: Various embodiments disclose a method for maintaining file versions in volatile memory. The method includes storing, in volatile memory for at least a first portion of a first sync interval, a first version of a file that is not modifiable during the at least the first portion of the first sync interval. The method also includes storing, in volatile memory for at least a second portion of the first sync interval, a second version of the file that is modifiable during the at least the second portion of the first sync interval. The method also includes subsequent to the first sync interval, replacing in nonvolatile memory, a third version of the file with the first version of the file stored in volatile memory. Further, the method includes marking the second version of the file as not modifiable during at least a first portion of a second sync interval.
Patent AU-2020292965-A1 (AU)
Title: Combination therapy comprising an anti-CD19 antibody drug conjugate and a PI3K inhibitor or a secondary agent
Inventor: ZAMMARCHI FRANCESCA
IPC: A61P35/00
Filed: 2020-06-08
Abstract: The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an anti-CD19 Antibody Drug Conjugate (anti-CD19 ADC) and a Phosphoinositide 3-kinase (PI3K) inhibitor or secondary agent.
Patent AU-2020314335-A1 (AU)
Title: Hinge for controlled door closing and opening with damper
Inventor: PLEŠNIK ALEŠ
IPC: E05F3/20
Filed: 2020-07-08
Abstract: The object of the invention is the hinge for controlled door closing and opening with damper which solves the technical problem of smooth and controlled closing and opening of the door before the end positions of the hinge, i.e. the open or closed position of the door. The damper fit surface (25) and the damper head fit surface (26) are always in contact with two of the limiting surfaces, i.e. two of the following: the damper stop on the housing for closing (21), the damper stop on the housing for opening (22), the damper stop on the guide for opening (23) and the damper stop on the guide for closing (24), whereby the damper (5) in the initial position constantly applies force in the direction of extension, meaning that the damper (5) constantly applies force to increase the distance between the damper fit surface (25) and the damper head fit surface (26), whereas the hinge guide (3) is dimensioned in such a way that the distance between the damper stop on the guide for opening (23) and the damper stop on the guide for closing (24) is smaller than the maximum distance between the damper fit surface (25) and the damper head fit surface (26).
Patent AU-2020345176-A1 (AU)
Title: Driver and system for threaded intramedullary nail retaining endcaps
Inventor: DEFOSSEZ HENRI
IPC: A61B17/88
Filed: 2020-09-10
Abstract: A driver for engaging an endcap of an intramedullary nail. The driver includes a handle extending along a longitudinal axis of the driver from a proximal end to a distal end. The handle having a handle channel extending longitudinally therethrough. The driver also includes a shaft extending through the handle channel from a proximal end to a distal end along the longitudinal axis. The shaft having a shaft channel extending longitudinally therethrough. The distal end of the shaft extends distally from the handle. The distal end of the shaft forms a driving element to be inserted into a head portion of the endcap. The driver further includes a retention pin slidably received in the shaft channel. The retention pin extends also extends along the longitudinal axis. The distal end of the retention pin is configured to reversibly lock the shaft to the head portion of the endcap.
Patent AU-2020346455-A1 (AU)
Title: Drug delivery formulations
Inventor: RECH ANTHONY
IPC: A61K47/34
Filed: 2020-09-11
Abstract: The present invention is directed to methods of treating psychiatric diseases and disorders comprising administering to a subject in need thereof an injectable formulation comprising risperidone, triblock and diblock copolymers wherein the concentration of the risperidone is 250-400 mg/mL and injection volume is 1 mL or less.
Patent AU-2020347715-A1 (AU)
Title: Camptothecin derivative and conjugate thereof
Inventor: ZHU YI
IPC: C07D491/22
Filed: 2020-09-17
Abstract: An antitumor pharmaceutical camptothecin derivative and an antibody-drug conjugate thereof. By means of a series of molecular structure modifications, an optimal camptothecin antitumor drug is obtained, so as to be more suitable as a drug for antibody conjugation.
Patent AU-2020382671-A1 (AU)
Title: Refrigerator
Inventor: LIM SEUNG EON
IPC: F25D23/00
Filed: 2020-11-13
Abstract: The present invention relates to a refrigerator. The present invention may comprise: a cabinet (100) having a storage space (121); and a machine room (201) disposed below the storage space (121). The machine room (201) may include a compressor (610), a condenser (620), and a heat dissipation fan (611) to implement a cooling system, and have an inlet (220a) and an outlet (220b) formed on the front side thereof. In addition, the compressor (610) and the heat dissipation fan (611) are disposed at the rear of the machine room (201), and the compressor (610) may be disposed in a space partitioned from a space in which the condenser (620) is disposed. At this time, the heat dissipation fan (611) may be disposed at the rear of the machine room (201) on the basis of the inlet (220a), and the compressor (610) may be disposed at the rear of the machine room (201) on the basis of the outlet (220b).
Patent AU-2020396948-A1 (AU)
Title: Blood pumps
Inventor: EARLES RONALD G
IPC: A61M60/825
Filed: 2020-12-02
Abstract: A blood flow assist system can include an impeller assembly including an impeller shaft and an impeller on the impeller shaft, a primary flow pathway disposed along an exterior surface of the impeller. The system can include a rotor assembly at a proximal portion of the impeller shaft. A secondary flow pathway can be disposed along a lumen of the impeller shaft. During operation of the blood flow assist system, blood can be pumped proximally along the primary flow pathway and the secondary flow pathway. The system can include a sleeve bearing distal the impeller. The system can include a drive unit having a distal end disposed distal a proximal end of the second impeller. The drive unit comprising a drive magnet and a drive bearing between the drive magnet and the impeller assembly.
Patent AU-2020409879-A1 (AU)
Title: Cell-free DNA fragmentation and nucleases
Inventor: LO YUK-MING DENNIS
IPC: C12Q1/6886
Filed: 2020-12-18
Abstract: Various methods, apparatuses, and systems are provided for detecting a genetic disorder in a gene associated with a nuclease, for determining an efficacy of a dosage of an anticoagulant, and for monitoring an activity of a nuclease. Measured parameter values can be compared to a reference value to determine classifications of a genetic disorder, efficiency, or activity. An amount of a particular base (e.g., in an end motif) at fragment ends, an amount of a particular base at fragment ends of a particular size, or a total amount of cell-free DNA fragments (e.g., as a concentration) can be used. Certain samples may be treated with an anticoagulant, and different incubation times can be used for certain methods.
Patent AU-2020414297-A1 (AU)
Title: Inflatable assembly for video display
Inventor: PINEAU EKKO
IPC: G03B21/585
Filed: 2020-11-25
Abstract: Assembly for video display, comprising: an inflatable structure with captive air (100) having a curved shape or a portion of a truncated sphere; a display support (110); and a holding system (105) between said inflatable structure (100) and said display support (110); the assembly being characterized in that the holding system (105) comprises latching members (105-a) distributed over the surface of the concave part of the inflatable structure (100) and complementary latching members (105-b) distributed over the convex surface of the display support (110); and in that all or some of said latching members (105-a) are connected to complementary latching members (105-b) positioned opposite, such that when the inflatable structure is inflated, said latching members of the inflatable structure, being connected to complementary latching members of the display support, become taut and serve to shape the display support.
Patent AU-2020437162-A1 (AU)
Title: Ignition-based protocols for pellet grills
Inventor: DONNELLY BRIAN C
IPC: A47J37/07
Filed: 2020-07-15
Abstract: Pellet grills including a control system that implements, manages, and/or controls various ignition-based protocols and/or processes are disclosed. An example pellet grill includes a cooking chamber, a burn pot, an ignitor, and a controller. The ignitor extends into the burn pot and is configured to ignite pellet fuel located within the burn pot. The controller is configured to command the ignitor to activate during a first duration. The controller is further configured to determine, following expiration of the first duration, whether a temperature of the cooking chamber has reached a threshold temperature. The controller is further configured, in response to determining that the temperature has not reached the threshold temperature, to command the ignitor to activate during a second duration.
Patent AU-2020444233-A1 (AU)
Title: Conjugates of a cell-binding molecule with camptothecin analogs
Inventor: ZHAO ROBERT
IPC: A61P35/00
Filed: 2020-06-19
Abstract: Provided are conjugates of camptothecin analogs with a cell-binding molecule of formula (I), wherein R1, R2, R3, R4, R5, X, L, n, m, T and ----- are defined herein. It also provides methods of making the conjugates of camptothecin analogs to a cell-binding agent, as well as methods of using the conjugates in targeted treatment of cancer, infection, and immunological disorders.
Patent AU-2020474539-A1 (AU)
Title: Connector for transfer of an implant to a cathether
Inventor: MCDONAGH DÓNAL
IPC: A61F2/95
Filed: 2020-10-29
Abstract: A connector for transfer of an implantable device from a loading tube to a delivery catheter, comprising: a first connecting portion (110) having a first distal end (120) configured to receive a delivery catheter (190); a second connecting portion (130) having a second proximal end (150) configured to receive a loading tube (180) extending towards the first distal end, the second connecting portion movably connected to the first connecting portion; and a biasing element (160) connecting the first and second connecting portions, having a relaxed configuration in which the first distal end and the second proximal end are spaced apart by a predetermined distance, and configured to bias the first distal end and second proximal end to the relaxed configuration when the first distal end and second proximal end are moved apart; such that when the loading tube is received, upon receiving the delivery catheter by the first connecting portion, the loading tube is biased to the delivery catheter to form a connection for the transfer of the implantable device.
Patent AU-2021200100-A1 (AU)
Title: System and method for wireless communication of glucose data
Inventor: MANDAPAKA ADITYA
IPC: A61B5/145
Filed: 2021-01-08
Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data.  
One such method includes, during a first interval, establishing a first connection between an 
analyte sensor system and a display device. During the first connection, the method includes 
exchanging information related to authentication between the analyte sensor system and the 
display device. The method includes making a determination regarding whether authentication 
was performed during the first interval. During a second interval, the method may include 
establishing a second connection between the analyte sensor system and the display device for 
transmission of an encrypted analyte value, and bypassing the exchanging of information related 
to authentication performed during the first connection. The method also includes, during the 
second interval, the analyte sensor system transmitting the encrypted analyte value to the display 
device, if the determination indicates that the authentication was performed during the first 
interval.
Patent AU-2021200347-A1 (AU)
Title: Bi-specific antigen-binding polypeptides
Inventor: CHEN YAN
IPC: C12N15/13
Filed: 2021-01-20
Abstract: The present invention provides antigen-binding polypeptides (e.g., bi-specific antigen
binding polypeptides) that specifically bind to a first and a second target antigen with 
high affinity. The present invention also provides novel antigen-binding polypeptides 
that specifically bind to HER2 and antagonize HER2 activation. The invention also 
provides nucleic acids encoding the antigen-binding polypeptides, recombinant 
expression vectors and host cells for making such antigen binding polypeptides.  
Methods of using antigen-binding polypeptide of the invention to treat disease (e.g., 
cancer) are also encompassed by the invention.
Patent AU-2021200689-A1 (AU)
Title: Energy efficient high power plasma torch
Inventor: CARABIN PIERRE
IPC: H05H1/28
Filed: 2021-02-03
Abstract: An apparatus is disclosed wherein an electric arc is employed to heat an 
injected gas to a very high temperature. The apparatus comprises four internal 
components: a button cathode and three cylindrical co-axial components, a first 
short pilot insert, a second long insert and an anode. Vortex generators are 
located between these components for generating a vortex flow in the gas 
injected in the apparatus and which is to be heated at very high temperature by 
the electric arc struck between the anode and cathode. Cooling is provided to 
prevent melting of three of the internal components, i.e. the cathode, the anode 
and the pilot insert. However, to limit the heat loss to the cooling fluid, the long 
insert is made of an insulating material. In this way, more electrical energy is 
transferred to the gas.
Patent AU-2021202183-A1 (AU)
Title: Resuscitator
Inventor: BIRD IAN
IPC: A61M16/08
Filed: 2021-04-09
Abstract: A resuscitator includes a flow control unit (5). The 
unit includes: (a) a peak inspirational pressure valve and 
5 controller ("PIP valve") for controlling the pressure of 
gas delivered to the lungs of a patient, such as an 
infant, during inhalation so that the pressure does not 
exceed a selected PIP pressure, (b) a positive end
expiratory pressure valve and flow controller ("PEEP 
10 valve") for allowing gas flow from the lungs through the 
PEEP valve during exhalation when the pressure in the 
lungs is above a selected PEEP pressure, and (c) a blow
off pressure relief valve that opens automatically if the 
gas pressure being delivered to the lungs exceeds a 
15 selected safe operation blow-off pressure that is higher 
than the selected PIP pressure.  
17579635_1 (GHMatters) P98438.AU.2 9/04/21
Patent AU-2021203889-A1 (AU)
Title: Novel method for producing antibody-drug conjugate
Inventor: NISHI YOSHIO
IPC: C07C233/54
Filed: 2021-06-11
Abstract: DCC - 10/06/2021 
ABSTRACT 
0 
OH 
Me Me 
ONO 
F R1 F R1 
(B) (C) 
A method for producing a compound represented by 
formula (C), the method comprising a step for converting a 
compound represented by formula (B) (wherein R' represents an 
amino group protected by a protecting group) by 
intramolecular cyclization into a compound represented by 
formula (C) (wherein R' is defined as above).
Patent AU-2021205649-A1 (AU)
Title: A closure for a multi-use drinks bottle
Inventor: GRANT JAMES
IPC: B01D39/20
Filed: 2021-01-11
Abstract: A closure and filter for a multi-use water bottle (2). The closure has a main body (4) having an outlet (16) through which fluid passes to be consumed by the user and an air valve (58) remote from the outlet to provide an air channel through the closure distinct from the fluid outlet to allow flow of air into the bottle as fluid passes through the outlet.
Patent AU-2021207461-A1 (AU)
Title: Anti-Gal3 antibodies and methods of use
Inventor: SUN DONGXU
IPC: A61P25/00
Filed: 2021-01-12
Abstract: Disclosed herein are antibodies and compositions used for binding to Gal3. Some embodiments allow for disrupting interactions between Galectin-3 (Gal3) and cell surface markers and/or proteins associated with neurological diseases and/or proteopathies, such as Alzheimer's disease. Additionally, disclosed herein are methods of treatment and uses of the antibodies or binding fragments thereof for the treatment of fibrosis, liver fibrosis, kidney fibrosis, cardiac fibrosis, pulmonary fibrosis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, sepsis, atopic dermatitis, psoriasis, cancer, brain cancer, breast cancer, colorectal cancer, kidney cancer, liver cancer, lung cancer, pancreatic cancer, bladder cancer, stomach cancer, hematological malignancy, neurological diseases and/or proteopathies. Furthermore, some embodiments provided herein can cross the blood-brain barrier and can be conjugated or otherwise associated with one or more payloads for the treatment of a neurological disease.
Patent AU-2021207504-A1 (AU)
Title: 4'-O-methylene phosphonate nucleic acids and analogues thereof
Inventor: WANG WEIMIN
IPC: C07H21/04
Filed: 2021-01-15
Abstract: The present invention relates to nucleic acids and analogues thereof useful as potent and stable RNA interference agents.
Patent AU-2021209353-A1 (AU)
Title: Animal Tracking Tag Case
Inventor: HEWITSON DEAN
IPC: H04M1/18
Filed: 2021-08-01
Abstract: This Patent claim is for the unique design of the plastic Casing for a small circular tracking device in 
conjunction with a silicon shroud around the outside of the casing to protect the unit from Water. This 
unique design will shockproof, Waterproof and Bite proof the tracking device to allow the small tracking 
device to be attached to an animals collar to provide Accurate Tracking.
I.
Patent AU-2021218035-A1 (AU)
Title: Textile hose
Inventor: WYRWIS BERND
IPC: D03D15/567
Filed: 2021-08-17
Abstract: Textile hose for encasing elongated objects, characterised by having a radially elastic 
outer layer (2) made from wear-resistant material and at least one inner layer (4) 
made from thermally insulating material.
Patent AU-2021235460-A1 (AU)
Title: System and method for determining a configuration of a measurement volume
Inventor: GUROVICH EVGENI
IPC: G01S1/08
Filed: 2021-03-11
Abstract: A method of determining a configuration of a measurement volume, the method may include: generating, by at least one transmitter, a transmitted magnetic field within the measurement volume; measuring, by at least one receiver positioned, a total magnetic field in the measurement volume at at least one receiver position and generating at least one receiver output signal; generating, by a processing unit, a measured dataset; comparing, by the processing unit, the measured dataset with at least one of at least two reference configuration datasets each for determined for one of at least two different configurations of the measurement volume; and identifying, by the processing unit, a reference configuration dataset of the at least two reference configuration datasets that corresponds to the measured dataset.
Patent AU-2021266196-A1 (AU)
Title: Isolated polynucleotides and polypeptides, construct and plants comprising same and methods of using same for increasing nitrogen use efficiency of plants
Inventor: ETZIONI ADI
IPC: A01H5/00
Filed: 2021-11-08
Abstract: Provided are isolated polypeptides which are at least 80 % homologous to SEQ ID NOs: 
496-794, 2898-3645, and 3647-4855, isolated polynucleotides which are at least 80% 
identical to SEQ ID NOs: 1-495 and 795-2897, nucleic acid constructs comprising 
same, transgenic cells expressing same, transgenic plants expressing same and method 
of using same for increasing fertilizer use efficiency, nitrogen use efficiency, yield, 
growth rate, biomass, vigor, oil content, photosynthetic capacity, seed yield, fiber yield, 
fiber quality, fiber length, and/or abiotic stress tolerance of a plant.
Patent AU-2021277483-A1 (AU)
Title: Para-amino-benzyl linkers, process for their preparation and their use in conjugates
Inventor: DESOS PATRICE
IPC: A61K47/68
Filed: 2021-05-18
Abstract: The present invention relates to para-amino-benzyl linker compounds useful for linking drug moieties to antibodies, to linker-drug compounds in which said para-amino-benzyl linker compounds are covalently linked to drug moieties, and to antibody-drug conjugates in which said para-amino-benzyl linker compounds are covalently linked to drug wherein said drug is enzymatically cleaved from the conjugate at a particular cell or tissue type targeted by said antibody.